St. Louis, MO (PRWEB) April 07, 2015
Attorneys handling national Xarelto lawsuits report progress in the multidistrict litigation* now underway in United States District Court in the Eastern District of Louisiana. According to court documents, a Status Conference was held on April 1, 2015 during which multiple topics were addressed including coordination between U.S. District Court and various state courts where Xarelto lawsuits are also underway, and discovery procedures. Xarelto lawyers provide regular Xarelto lawsuit news updates and detailed information about Xarelto side effects at their website, XareltoContingencyLawsuitCenter.com.
Xarelto lawsuits alleging the drug had caused severe internal bleeding and hemorrhagic stroke were first consolidated in Louisiana in December of 2014. The litigation, known as Xarelto (Rivaroxaban) Products Liability Litigation now includes a total of 311 pending actions which have originated throughout the nation, according to court documents as of April 6, 2015.
Each of these 311 actions shares common questions of fact, alleging that Xarelto caused severe internal bleeding, stroke, or another serious health issue, in each of the plaintiffs, according to court documents. Furthermore, these Xarelto lawsuits make a common allegation that Janssen Pharmaceutical and Development, the company responsible for manufacturing and marketing Xarelto, failed to share its knowledge of the drug’s defects, according to court documents. Given that the drug has no known antidote to stop severe bleeding, which is known by the pharmaceutical company and the public, plaintiffs assert the severe bleeding risks should have been clearly communicated to medical professionals and consumers, according to court documents.
Plaintiffs in this case include individuals who allege they have suffered from severe bleeding events, as well as family members who allege they have lost loved ones as a result of Xarelto side effects, according to court documents. The U.S. District Judge assigned to the case is Eldon E. Fallon.
The multidistrict litigation is still in very early stages and attorneys handling Xarelto lawsuits are accepting new claims at this time, according to the Onder Law Firm. The next status conference is scheduled for May 13 at 9 am.
Lawyers representing individuals and families around the nation in Xarelto lawsuits believe that individuals and the families of individuals who experienced internal bleeding, stroke, or another serious health problem while taking Xarelto may be entitled to real compensation by filing a Xarelto lawsuit. Nationally-renowned for groundbreaking work in drug and product safety litigation against multi-billion dollar corporations, the Onder Law Firm’s Xarelto attorneys have committed their significant resources to providing expert legal representation to men and the family members of men who believe they may have grounds to file Xarelto lawsuits. Individuals and family members of individuals who meet this description are entitled to a no-cost, no-obligation consultation through the firm’s Xarelto Contingency Lawsuit website.
The Onder Law Firm welcomes Xarelto lawsuit case inquiries from law firms in regards to handling them or working as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling Xarelto lawsuits at http://www.XareltoContingencyLawsuit.com.
- Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592